Michael Pohl
Impact in
-
- Gastric Cancer Management and Outcomes
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Surgical Treatments
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
Papers in
- Oncology 16
- Colorectal Cancer Treatments and Studies 10
- HER2/EGFR in Cancer Research 3
-
- Gastric Cancer Management and Outcomes 9
- Co-authors
- Wolff Schmiegel (9 shared papers)Anke Reinacher‐Schick (4 shared papers)Andrea Tannapfel (9 shared papers)Roland Schroers (4 shared papers)Susanne Klein‐Scory (4 shared papers)Alexander Baraniskin (3 shared papers)Swetlana Ladigan‐Badura (4 shared papers)Susanne Hegewisch-Becker (2 shared papers)
In The Last Decade
Michael Pohl
30 papers receiving 3.6k citations
Michael Pohl's Hit Papers
Peers
Comparison fields: 5 of 74
- Pulmonary and Respiratory Medicine 1.8k
- Oncology 853
- Surgery 933
- Cancer Research 208
- Drug Discovery 1
Countries citing papers authored by Michael Pohl
This map shows the geographic impact of Michael Pohl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Pohl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Pohl more than expected).
Fields of papers citing papers by Michael Pohl
This network shows the impact of papers produced by Michael Pohl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Pohl. The network helps show where Michael Pohl may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Pohl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial Hit paper breakdown → | 2019 | 1880 |
| 2 | Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial Hit paper breakdown → | 2016 | 585 |
| 3 | 2021 | 231 | |
| 4 | 2017 | 165 | |
| 5 | 2017 | 133 | |
| 6 | 2019 | 72 | |
| 7 | 2021 | 72 | |
| 8 | 2013 | 60 | |
| 9 | 2022 | 58 | |
| 10 | 2015 | 54 | |
| 11 | 2020 | 43 | |
| 12 | SMAD4 mediates mesenchymal-epithelial reversion in SW480 colon carcinoma cells. | 2010 | 38 |
| 13 | 2018 | 37 | |
| 14 | 2008 | 29 | |
| 15 | 2011 | 27 | |
| 16 | 2016 | 22 | |
| 17 | 2009 | 18 | |
| 18 | 2017 | 18 | |
| 19 | 2017 | 16 | |
| 20 | 2008 | 13 |
About Michael Pohl
Michael Pohl is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Periodontics, having authored 33 papers that have together received 3.6k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (10 papers), Gastric Cancer Management and Outcomes (9 papers), Cancer Genomics and Diagnostics (3 papers), HER2/EGFR in Cancer Research (3 papers), Angiogenesis and VEGF in Cancer (2 papers), Clinical Laboratory Practices and Quality Control (1 paper), Ocular Oncology and Treatments (1 paper) and Protein Degradation and Inhibitors (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.8k citations), Oncology (853 citations), Surgery (933 citations), Cancer Research (208 citations) and Drug Discovery (1 citation). Michael Pohl has collaborated with scholars based in Germany, Spain and Türkiye. Frequent co-authors include Wolff Schmiegel, Anke Reinacher‐Schick, Andrea Tannapfel, Roland Schroers, Susanne Klein‐Scory, Alexander Baraniskin, Swetlana Ladigan‐Badura, Susanne Hegewisch-Becker, Thomas Mika and Ullrich Graeven. Their work appears in journals such as European Journal of Cancer, Annals of Oncology, Molecular Oncology, International Journal of Cancer and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.